Cellectis
CLLS
#7722
Rank
HK$2.65 B
Marketcap
HK$26.38
Share price
-11.32%
Change (1 day)
171.55%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: HK$2.65 Billion

As of March 2026 Cellectis has a market cap of HK$2.65 Billion. This makes Cellectis the world's 7722th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.65 B-28.44%
2025HK$3.70 B232.03%
2024HK$1.11 B-35.15%
2023HK$1.72 B125.2%
2022HK$0.76 B-74.4%
2021HK$2.98 B-69.78%
2020HK$9.88 B70.16%
2019HK$5.80 B1.35%
2018HK$5.73 B-27.22%
2017HK$7.87 B67.72%
2016HK$4.69 B-43.59%
2015HK$8.32 B145.02%
2014HK$3.39 B554.22%
2013HK$0.51 B

End of Day market cap according to different sources

On Mar 11th, 2026 the market cap of Cellectis was reported to be:

HK$2.14 Billion
by Nasdaq info icon info icon
HK$2.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$622.43 B 23,360.09%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
HK$8.53 B 221.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
HK$13.28 B 400.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$3.59 B 35.38%๐Ÿ‡บ๐Ÿ‡ธ USA